secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2023-04-25T23:59:59+00:00
Accession:  0001214659-23-005946
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro updates investor presentation for April 2023; no material new disclosures
--------------------------------------------------------------------------------

- Company furnished an updated corporate presentation (Exhibit 99.1) used for investor meetings.
- Presentation provides overview of therapeutic drugs for Alzheimer's and other neurodegenerative diseases.
- Information furnished under Regulation FD; not deemed filed for SEC or incorporated by reference.
- No specific pipeline updates, financial data, or clinical milestones disclosed with this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923005946/0001214659-23-005946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923005946/r4252308k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-23-005946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer